Tens of thousands of patients with advanced lung diseases may be eligible to be considered
as potential candidates for lung transplant around the world each year. The timing of referral …

Cystic fibrosis (CF) remains the most common indication for lung transplantation in children
and the third most common in adults and has the highest median survival posttransplant for …

Solid organ transplantation is a life‐saving procedure for patients in the end stage of heart,
lung, kidney, and liver failure. For patients with more than one failing organ, simultaneous …

Cystic fibrosis (CF) may cause a spectrum of hepatobiliary complications, including portal
hypertension, multilobular cirrhosis, and liver failure. Current guidelines on the detection …

Combined heart and liver transplantation is an infrequent but growing procedure due to
increasing need in the adult congenital heart disease and cardiac amyloid populations …

This book chapter delivers a succinct overview of simultaneous liver transplantation with
other organs, with a primary emphasis on simultaneous liver-kidney transplantation (SLK). It …

Combined liver-lung transplantation (CLLT) is a rare, life-saving procedure to treat
concomitant lung and liver disease. There have been 93 combined lung and liver …

Cystic fibrosis (CF) is an autosomal recessive disease characterized by mutations in the
gene that encodes for the cystic fibrosis transmembrane conductance regulator protein …

Background. There is debate whether simultaneous lung-liver transplant (LLT) long-term
outcomes warrant allocation of 2 organs to a single recipient. We hypothesized that LLT …

Liver dysfunction is an increasingly common finding in patients evaluated for lung
transplantation. New or worsening dysfunction in the perioperative period, defined by …